InvestorsHub Logo
Followers 88
Posts 1175
Boards Moderated 0
Alias Born 09/10/2017

Re: exwannabe post# 401463

Sunday, 09/12/2021 7:43:47 PM

Sunday, September 12, 2021 7:43:47 PM

Post# of 704201
Yes, Advent’s single cleanroom in London can produce 4 or 5 batches a month, but it may be wrong to assume that it will be the same for the cleanrooms at Sawston, since Advent had them specifically designed knowing the initial startup production will use the manual process. Have you heard of isolators? If each process step, and each patient’s cells are isolated, it would be possible to “potentially” produce the 40+ batches per month that Northwest Bio has discussed in two cleanrooms. Installing isolators is expensive and normally wouldn’t make sense for a closed automated process, but for a prolonged interim manual step, it would make sense, and it may be what Advent has done to produce revenue and train new staff, while they work on the Flaskworks’ automated process.

The Flaskworks device as of the time they bought the company was only useful for pre-clinical research


That’s incorrect. Where did you get this information? Did you make it up?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News